Try our Advanced Search for more refined results
Life Sciences - October, 2020
354 articles
- Alabama Justices Urge High Court To Overturn Roe
- Feds Pressed On Bid To Nix Gilead HIV Patent Counterclaims
- COVID-19 Drugmaker Leads 2 Latham-Led Cos.' $373M IPOs
- Cozen O'Connor Adds 2 Ex-Kilpatrick IP Attys
- Pfizer Unit Agrees To $4.2M Enviro Remediation In NJ
- Rival Lab Co.'s CEO Stole Trade Secrets As Student, Suit Says
- Fresenius Fights $11.5M Atty Fee Bid In Medicare Case
- Gov't Contracts Of The Month: Weapons, 5G, Virus Treatments
- FDA Says Groups Can't Sue Over Drug To Reduce Cattle Gas
- Wyden Leans On Trump To Enforce N. American Trade Deal
- 3 Reasons Medical Offices Remain Attractive Amid Pandemic
- High Times Subsidiary Says Fake Urine Maker Owes Royalties
- Mylan, Pfizer Unit Merger Clears Final Hurdle With FTC Deal
- Book Review: Did The High Court Cause Mass Incarceration?
- Taxation With Representation: Latham, Pillsbury, Baker
- Should GCs Fear The DOJ's Power To Bankrupt?
- Cross-Border Discovery Trends 1 Year After 2nd Circ. Ruling
- Decoupling From China: Part 3 — Oversight And The Election
- UK Litigation Roundup: Here's What You Missed In London
- Imerys Gets Court OK For $223M Stalking Horse Bid
- AstraZeneca Gets $287M Vaccine Contract From Army
- Hemostemix Says Data Co. Is Holding Drug Trial Data Captive
- Pa. College Dodges Claims Over Student's Medical Pot Use
- DOJ, Medtronic Agree To $9M Deal Over Restaurant Kickbacks
- 3 IPOs Exceed $1B Amid Market Volatility, Others Delay
- Decoupling From China: Part 2 — Security Requirements
- Coronavirus Litigation: The Week In Review
- 9th Circ. Sinks Pharma Cos.' Suit Against Hawaii AG
- FTC Says Shkreli Can't Relitigate Authority Challenge
- 3rd Circ. Backs WashU's $32M Patent Contract Win
- Persuasion Skills Attys Can Learn From Political Speeches
- Drugmaker In IP Fight With Mylan Calls EPO Ruling 'Irrelevant'
- Biogen Says Fed. Circ. Patent Ax Ruling 'Breaks New Ground'
- NY AG's Opioid Epidemic Jury Trial Set For Early 2021
- Feds Defend Warrant In $94M Drug Return Fraud Appeal
- Eli Lilly Scores $375M For COVID-19 Treatment
- Fight Over Sackler Deal On Hold For Purdue Ch. 11 Plan Talks
- SEC Settles Suit Over Allegedly Misleading COVID-19 Claims
- Dems Urge Hearing On 'Outsized' DOD Role In Vaccine
- Decoupling From China: Part 1 — Legislation And Funding
- Courts Shouldn't Consider Bodily Injury Claims In Opioid Suits
- Zimmer Says No Sex Bias Behind Exec's Severance Denial
- Reflections On My 1st Judicial Election Amid Racial Tensions
- Pharmacies Sue FDA Over Compounded Drug Agreements
- Drugmaker Wins Appeal On Myeloma Treatment Authorization
- AGs In A Pandemic: Ellison Talks Minnesota Housing
- 3M Makes Deal With Ex-Marine Over Massive N95 Mask Scam
- IP Profs Want Justices to Resolve Split Over Jury Verdicts
- EPA Greenlights Dicamba Use After 9th Circ.-Ordered Review
- Real Estate Firms Lean Bearish, Eye Logistics And Biotech
- NJ Justices Question J&J Taxes On Coverage Beyond State
- Ind. Appeals Court Mulls Venue In Medtronic Contract Row
- Mass. High Court Says Pot Patients Cannot Get Reimbursed
- Justices Told FCA Circuit Split Poses 'Far-Reaching' Threat
- Alsup Grants Sanctions, Bemoans Ex-Player's MLB 'Crusade'
- Calif. Pot Testing Lab Says Mayor Sought Bribe For Permit
- Purdue Creditors Object To Sackler Part Of $8B DOJ Deal
- J&J Flags 'Moral Hazard' In Imerys' Del. Ch. 11 Disclosure
- Coronavirus Regulations: A State-By-State Week In Review
- High Court To Mull Taking Up Abortion Case This Week
- Judge Wants New Bellwether List In Cook Vein Filter MDL
- Key Gov't Tools For Addressing National PPE Shortages
- Weighing Litigation Vs. Arbitration Amid Court Disruptions
- Exact Sciences Buys Cancer Detection Cos. For Up To $2.56B
- Greenberg Traurig Snaps Up IP Partner In LA From Jones Day
- J&J, 3M Urge Congress To Back PTAB Discretionary Denials
- AIG Sues McKesson Over Opioid Litigation Coverage
- COVID-19 Drug Developer Joins IPO Pipeline In Packed Week
- Judge Lourie Reflects On IP's Rise From 'Backwater' Of Law
- 2nd Circ. Won't Revive Apotex's Unfair Competition Suit
- Teva, Cooper Slam Bid To Send IUD Defect Suits To Calif. MDL
- Feds Float Drop Of Preterm Birth Drug Approval, Women Say
- Rakoff Opens SDNY Fraud Trial With Dig At Pence On Virus
- 'Cobra Sexual Energy' Maker Inks $100K Deal In False Ad Suit
- Avoiding Shareholder Class Actions After FDA Drug Denials
- 1st Circ. Backs 4-Year Sentence Of Insys Opioid 'Drug Pusher'
- How Attys Can Guard Against Rising Settle-And-Sue Claims
- Pfizer Pushes 2nd Circ. To Ditch Patients' Lipitor Claims
- Baker McKenzie, Ropes Steer Up To $4B Bayer-AskBio Deal
- Chevron Deference's Future In Doubt If Barrett Is Confirmed
- Lannett Drug Price-Fixing Settlement Gets Del. Judge's OK
- Business Groups Rally Behind J&J's $465M Opioid Appeal
- 9th Circ. Judge Doubts Monsanto's $25M Roundup Argument
- Ropes, Latham Steer Cancer-Focused Biotech's $120M Float
- Pa. Stores Accused Of Wrongly Charging Sales Tax On Masks
- Health Hires: Polsinelli, Akerman
- Lens Buyers Float $30.2M Deal For ABB Optical To Leave Suit
- UK Litigation Roundup: Here's What You Missed In London
- Law Firm Tips For Attracting, Retaining Attys During Pandemic
- Gilead's Remdesivir Wins 1st FDA Full Approval For COVID-19
- FDA Advisers Fear Coronavirus Vaccines Won't Help Enough
- Walmart Sues Feds To Get Ahead Of Possible Opioid Suit
- Whistleblower Cheat Sheet: Trump Faces A New Wave
- IP Atty Asks 9th Circ. To Revive Bausch Whistleblower Suit
- Shkreli Says FTC Can't Nix Challenge To Authority
- Invisalign Maker Expands Scanner Patent Fight To Texas
- AbbVie Gets AndroGel Monopoly Case Moved To NJ
- Finding A Path Forward To Regulate The Legal Industry
- Vaping And COVID-19: Plausibility And Causality
- Coronavirus Litigation: The Week In Review
- Loeb & Loeb Adds Ex-McGuireWoods IP Litigator To NY Office
- CORRECTION: Gene Therapy Startup Gets $107M In Series A Round
- Insurer Says Judge Erred In Sending Virus Suit To State Court
- Calif. High Court Won't Review $21M Monsanto Verdict
- Eli Lilly Fights To Challenge Teva Migraine IP Despite Deal
- Cybersecurity Co. McAfee Leads 3 IPOs With $740M Debut
- Amgen Cholesterol IP Suit Restarts As EPO Decision Looms
- Lawyering While Parenting: A Day In A Dad's Pandemic Life
- Judiciary Panel Sends Barrett Nomination To Full Senate
- 3 False Claims Act Takeaways From Purdue's Opioid Deal
- Meet The Attys Guiding Purdue On $8B DOJ Opioid Plea Deal
- Where DOJ's Opioid Blitz Stands After Purdue's Criminal Case
- Sackler Factor Could Sink Purdue's $8B Opioid Deal With DOJ
- 1-800 Contacts Gets Final Approval On $15M Antitrust Deal
- Nevada Pot Regulators Collect $63K In Fines Over Violations
- Coronavirus Regulations: A State-By-State Week In Review
- Whistleblower's Claims Against ICE Contractor Set For Trial
- Atty Rips Feds' 'Unbridled Attempt' To Steer China Tariff Suits
- 8 Firms Steer 5 Blank-Check IPOs Exceeding $1.3B Total
- DOJ Can Jump Into Teva Suit, But Only On Limited Basis
- Union Funds Lose Bid To Pause Akorn's Ch. 11 Confirmation
- Fed. Circ. Ruling Is Troubling For Generic Drug Manufacturers
- Lawyering While Parenting: A Day In A Mom's Pandemic Life
- 2nd Circ. Gives Teeth To Omnicare Securities Fraud Standard
- Pa. Justices OK State's Jurisdiction Over J&J In Mesh Cases
- Medical Pot Patient Sues Pa. County After Failed Drug Test
- Supplement Makers Must Face Joint Pill False Ad Suit
- 5 States Poised To Legalize Pot At The Ballot
- 9th Circ. Revives Abbott Labs Worker's Age Bias Claim
- Purdue To Pay $8B In Penalties In DOJ Opioid Plea Deal
- Valeant Securities Suit Was Launched On Time, 3rd Circ. Told
- Scientist Says USCIS Ignored Reputation Of Washington Univ.
- Opioid Settlements Stymied By Atty Fee Demands, AGs Say
- Atty Says Medical Device GC Ousted Him For Not Hiding Cash
- Full Fed. Circ. Skips Split Immunity Ruling In Cancer IP Row
- Sanofi Wants Antitrust Claims Over Insulin Pen Pared Down
- Wilson Sonsini Taps New Europe Business Development Head
- Daiichi Faces Patent Suit Over New Breast Cancer Drug
- DC Circ. Won't Rethink HHS Cuts To Medicare Drug Program
- 2 Fed. Circ. Rulings Show Importance Of Correct Inventorship
- Health Care Co. Objects To Nov. Trial In Cancer Patent Fight
- Abbott Says Ex-Worker Using TMs To Sell COVID-19 Tests
- Questions Raised By FDA's New Lab Test Policy
- Trulieve Slams 'Ham-Fisted' Sanction Bid In Hiring Dispute
- 10th Circ. Upholds IRS Summons For State Info On Pot Cos.
- 5 Cost-Cutting Strategies For Corporate Legal Departments
- Judge Tosses Co.'s Ch. 11 Filing Over Canadian Pot Plans
- WTO Holds Off On Waiving IP For COVID-19 Vaccines
- 10 Firms To Steer 8 IPOs Exceeding $2B As October Stays Hot
- Justices Urged Not To Let Arbitrator Decide Venue Question
- Preparing The Next Generation Of Female Trial Lawyers
- Mentorship Is Key To Fixing Drop-Off Of Women In Law
- What BigLaw Can Do To Actually Retain Female Attorneys
- Female Attorneys Gain Ground In Battle For Clerkships
- These Firms Have The Most Women In Equity Partnerships
- Wearing Natural Hair In BigLaw
- 6 Russian Officers Indicted Over Massive Cyberattack
- Trump Admin. Hit With Another Suit Over Vaccine Contracts
- High Court Won't Hear FDA Stimulant Seizure Suit
- How A Biden Administration Would Shape IP Policy
- 5 Ways Firms Can Avoid Female Atty Exodus During Pandemic
- In Their Own Words: Being A Woman In BigLaw
- Law360's Glass Ceiling Report: What You Need To Know
- Glass Ceiling Report: How Does Your Firm Measure Up?
- CVS, Walgreens Tapped To Dispense COVID-19 Vaccine
- Teva, Workers Reach Deal To Settle 401(k) Fee Suit
- Purdue, Sacklers Say Atty-Client Privilege Shields Documents
- Biotech, Med Device Companies Price 6 IPOs Totaling $712M
- Kilpatrick Townsend Adds Life Sciences Team From DLA Piper
- Ohio Pot Co. Wins Second Shot At Dispensary Licenses
- Texas Cotton Farmers Get Pesticide Drift Suit Partially Revived
- Patients Say Ill. Allergan Ruling Is Irrelevant To Implant MDL
- Whistleblower Firm Sued Over Fees In GlaxoSmithKline Suit
- Full Fed. Circ. Won't Review Inventorship Row Over Cancer IP
- Pot Co. Cancels $3.9M Stock Sale Over Short Seller Fears
- High Court Faces Preemption Dilemma In Drug Benefits Case
- Consumer Slams ViSalus Trial Redo Bid In $925M TCPA Row
- Thiel-Backed Blank-Check Co. Leads 2 IPOs Raising $635M
- How The State And Local Regulatory Landscape Is Expanding
- Lowenstein Sandler Adds Antitrust Partner Jonathan Lewis
- Simpson Reps Blackstone In $14.6B BioMed Realty Deal
- St. Jude Can't Revive Heart Valve IP Challenge At Fed. Circ.
- Coronavirus Litigation: The Week In Review
- Ropes & Gray Nabs Health Partner From Hogan Lovells
- Pot Co. Says Stock Buys Disprove $144M 'Sham' Asset Plot
- Trump Admin. Sued For Withholding Virus Vaccine Contracts
- US Merck Prevails In Vaccine IP Battle Against Pfizer
- State AGs Bash DOJ's Proposed Opioid Deal With Purdue
- Top Mallinckrodt Creditor Opposes Del. Ch. 11 Strategy
- Whistleblower In Merit Medical Case Gets Closure, And $2.7M
- Allergan, Teva Sanctioned For Flouting Opioid MDL Discovery
- Justices Urged To Block Arbitration In Dental Suppliers' Fight
- Green Groups Call EPA Chemical Emissions Rule 'Weak'
- New Mexico Can't Block Nonresidents' Medical Pot Access
- Man Allergan Texted About Botox Seeks Cert. In TCPA Suit
- AstraZeneca Inks $486M COVID-19 Antibody Deal With Gov't
- WuXi PharmaTech Dodges Securities Suit
- GNC Gets Ch. 11 Plan Confirmed After $780M Stores Sale
- Chancery Ignored Precedent By Axing Suit, Del. Justices Told
- J&J Keeps Pushing For Destruction Of Asbestos ERISA Suit
- 12 Firms Vie For Lead In Kodak Investors' Stock Trading Suits
- How COVID-19 May Rattle Companies' Supply Chains
- Fed. Circ. OKs Ax Of Medtronic Suit In $112M Patent Dispute
- Lawyers Must Fight Voter Suppression This Election Season
- FTC, State AGs Say Humira Judge Botched Actavis Reading
- What Patent Prosecution Market Size Means For Cos., Counsel
- Target Beats Suit Over Pharmacy Prescription Flub
- Patent Law Is Just The Beginning For High Court In Arthrex
- Shire Owes $45M Milestone After Life Science Acquisition
- Tomax Seeks To Duck Blame Over Failed $57M PPE Deal
- Humira Buyers Get Backing Against AbbVie's 'Patent Thicket'
- High Court PBM Case Could Be Turning Point In 20-Year Fight
- Fed. Circ. Backs Sanofi, Regeneron PTAB Win Over Amgen
- J&J Strikes $5B Deal Pushing 3,000 Opioid Suits Toward End
- Predictions For High Court Review Of Arthrex
- Why Online Mediation May Be Here To Stay
- 'Trump Cards' For Drug Discounts Look Unlawful, Dems Say
- Mass. Pot Shop Can't Shake Recreational Licensing Loss
- Coronavirus Regulations: A State-By-State Week In Review
- Mallinckrodt Plans $1.6B Opioid Trust In $5.3B Del. Ch. 11
- Theranos Founder Elizabeth Holmes Can't Shake New Charges
- Justices Pass On Transgender Inmate's Gender Surgery Suit
- Mylan Can't Expedite Novartis Blood Transfusion IP Fight
- High Court Rejects Ex-NFL Player's Pot Legalization Bid
- 3 Firms Steer PE Deal For $2.25B Chemical Products Maker
- Supreme Court Will Decide If PTAB Judges Are Constitutional
- Court Hints Boston May Win Costs In False Drug Test Suit
- J&J Opens Appeal By Assailing 'Radical' $465M Opioid Verdict
- Eye Device Maker Gets Rival Product Blocked During IP Fight
- Allergan Escapes Ill. Suit Over Defective Breast Implants
- Drug Cos. Fight Class Cert. For 'Opioid Babies' In MDL
- Prosthetic Maker Reaches Deal Over FTC's Merger Unwinding
- 9th Circ. Revives CVS Joint Pain Pills False Ad Suit
- COVID-19 IP Catch-Up: Moderna Promises & Ed Sheeran
- MiMedx Investors Get Initial OK For Fraud Deal, $3.5M In Fees
- Biopharma Co. Leads Pack Of 5 IPOs Totaling $650.8M
- Texas Justices Bounce Back Fen-Phen Atty Malpractice Fight
- Health Hires: Goodwin, Greenberg Traurig
- MVP: White & Case's Robert Milne
- Opioid MDL Bellwether Trial Delayed Amid COVID-19 Fears
- Early Takeaways From SEC's FY 2020 Fraud Enforcement
- Negotiation Class Wants 6th Circ. Full Review In Opioid MDL
- Clients Have The Power To Promote Wellness At Law Firms
- Cannabis Regs: Mich. To Ease Recreational Pot Licensing
- Pandemic Can't Delay Landmark Opioid Trial, Judge Told
- High Court Punts FDA Bid To Revive Abortion Pill Restriction
- BioMedomics Faces $6.1M Suit Over COVID-19 Antibody Test
- Senate Bill Would Sanction Foreign COVID-19 IP Hackers
- Del. Judge Won't Invalidate 'Smile Designer' Patents
- Stryker's Trial Win Over Surgery Death Upheld On Appeal
- Moderna Won't Enforce COVID-19 Patents During Pandemic
- Becton Dickinson Settles Watchdog's Race Bias Probe
- Costco Dodges Suit Over Roundup Marketing
- Takeda Asks 2nd Circ. To Flip Actos Rulings
- Judge Says Dentist's Virus Suit Should Return To State Court
- Appellate Courts Should Welcome Well-Crafted Amicus Briefs
- What To Know About FDA's 'Intended Use' Proposed Rule
- Allergan Implant Patients Say State Claims Should Proceed
- Minerva Takes Assignor Estoppel Fight To Supreme Court
- Vt. Legalizes Recreational Cannabis Sales, Imposes Taxes
- CVS Accused Of Stiffing Arizona Pharmacists On OT
- Pence, Harris Brawl Over Trump's Judges, Bigger High Court
- Gilead Accused Of Antitrust Scheme Over HIV Meds
- Dems Float Bill To Block $250M HHS COVID-19 Ad Campaign
- Veterans Urge 9th Circ. To Hear Challenge To DEA's Pot Status
- Two TPG-Backed SPACs Among 5 Raising Total $1.8B In IPOs
- Calif. Consumers Want 2nd Shot At Lipitor Antitrust Subclass
- Florida Tells State High Court That Pot License Law Is Valid
- MVP: Sullivan & Cromwell's Matthew Hurd
- Regeneron Says Feds' Kickback Theory Makes Charity Illegal
- MVP: Weil Gotshal's Derek Walter
- Generics Worry Fed. Circ. Blew Up 'Routine' Labeling Practice
- Walmart Is Sued Over Intoxicated Driver's Crash That Killed 3
- 4 Developments As FDA Vaccine Guidance Stokes Trump's Ire
- NY Prof. Gets Prison For Pilfering Cancer Grant Money
- Investor Wants Attys Sanctioned In CBD Co. Securities Suit
- Biotech Co. Wants $881M Cannabinoid IP Fight Arbitrated
- Ex-Theranos CEO Slams Safeway, Walgreens Fraud Charges
- Humira Buyers Ask 7th Circ. To Revive 'Patent Thicket' Case
- Avadel Pharma Gets OK For Liquidation Plan After IRS Deal
- Mylan Says 3rd Circ. Ruling Can't Boost EpiPen Antitrust Suit
- WTO Offers Cautious Optimism On COVID-19 Trade Recovery
- Coronavirus Regulations: A State-By-State Week In Review
- Zest Soap Maker Gets Approval For Ch. 11 Liquidation Plan
- Storage Tank Co. Can't Nix Destroyed Embryo Suit
- What Hiring Law Firms Should Consider Instead Of Grades
- How To Navigate A Hardening D&O Insurance Market
- 1st Circ. Presses Ex-Aveo CFO On Candor With Analyst
- MVPs: Latham's Daniel Brown And Ken Schuler
- 4 Firms Guide $850M Tie-Up Of Medical Products Cos.
- Justices Eye Arkansas PBM Law's Impact On Workers
- Fed. Circ. Mulls New Trial In Vectura's $107M Inhaler IP Win
- Drug Distributors Fear 'Super-Spreader' Trial In Opioid MDL
- SDNY Jury Trial Of Ex-MiMedx Execs Set For End Of October
- Key Highlights As House Dems Drop Hammer On Drugmakers
- Former Desmarais Atty Starts New PTAB Firm
- Justices Won't Hear Widow's Appeal Over Heart Drug Warning
- 8 More IP Cases The Justices Rejected At 1st Conference
- Pot Co. Trulieve Accused Of Hiding Discovery In Hiring Row
- Chancery Orders Walmart To Turn Over Opioid Oversight Docs
- Pfizer, Regeneron Hit With Patent Suits Over COVID-19 Tech
- High Court To Weigh States' Ability To Rein In Drug Middlemen
- MVP: Covington & Burling's Jennifer Plitsch
- FCA Materiality Standard's Odd Application To Payment Terms
- Justices Delay Arthrex Petitions, But Deny Expansion Bids
- Trump Should Revisit Flawed Plan To Lower Drug Prices
- Cancer-Focused Firm Leads 4 IPO Launches Totaling $353M
- GSK Can't Get High Court Review In Avandia Marketing Fight
- Justices Skip Opioid Treatment Case Disputing PTAB's Power
- Trustee Flags Gaps In J&J Talc Supplier's Ch. 11 Plan
- Judging A Book: Schroeder Reviews 'Collegiality'
- Now Is The Time To Go Digital With Compliance Training
- 2 Firms Drive $13.1B Heart Disease Treatment Developer Deal
- Law360 MVP Awards Go To Top Attorneys From 76 Firms
- House Panels Launch Probe Into DOD Virus Aid Bill Spending
- Simpson Thacher Reps Academy For Undersized $203M IPO
- Abbott Shakes ERISA Suit Over Pilfered Retirement Savings
- J&J Unit Wins Block Against Seller Of Counterfeit Implants
- How Rookies Should Prep For A Unique Supreme Court Term
- Health Hires: Covington, Baker Donelson, Wiley Rein
- 1 Firm Seizes Spotlight Amid September's IPO Surge
- What One Scrapped Opinion Might Say About Judge Barrett
- Patents A Key Focus As Drug-Pricing Debate Intensifies
- Supreme Court Cheat Sheet: The Biggest Cases To Watch
- Canadian Pot Co. Can't Slip Suit Over $144M 'Sham' Asset Buy
- Dialysis Co. Agrees To $853M Sale Amid Investor Class Deal
- Amarin Tells Fed. Circ. Vascepa Patents Didn't Get Fair Shot
- COVID-19 IP Catch-Up: Reflecting On Priorities, Shifting Trials
- Medicare Entitlement Rulings Help Bankrupt Health Providers
- The Heeding Presumption's Evolving Role In Pharma Suits
- Agrify Corp. Gains New GC From Ocean Spray
- Overcoming The Pandemic's Hurdles To Pro Bono Work
- UK Litigation Roundup: Here's What You Missed In London
- GOP Vows Virus Infections Won't Slow Barrett Confirmation
- Split Fed. Circ. Revives GSK's $235M Win Against Teva
- Trump Tests Positive For COVID-19
- Fla. Nursery Says Drug Laws Don't Apply To State Licenses
- Ohio High Court Holds Amazon Not Liable For Teen's Death
- 5 Health Cases Attys Should Know As High Court Term Starts
- Pfizer Shorted NYU On Cancer Drug Royalties, Suit Says
- Pot Co. Ayr Invests $39M In Ohio And Pa. Cannabis Markets
- Shareholders Can't Fish Through Teva Texts, Judge Told
- Akorn Seeks Del. Ch. 11 OK For $9M Stockholder Suit Deal
- DC Circ. Studies What Costs Indian Health Service Must Cover
- RICO Claims Trimmed In SF Opioid Case
- Teva Unit Tells High Court Not To Take Up Horizon's IP Loss
- J&J Cos. Sue To Block Exec's Move To Smith & Nephew
- Drug Pricing Site Says Trump's Order Supports Antitrust Suit
- Importers Call For CIT Panel To Handle China Tariff Challenge
- Deals Rumor Mill: Asda, Lonza, Reckitt Benckiser
- College Coronavirus Q&A: Duke's General Counsel
- Bristol-Myers Squibb Escapes Investor Suit Over Clinical Trial
- Mass. Priest Targeted By SEC Says Trades Were By The Book
- Best Practices For Presenting Exhibits In A Remote Deposition